Journals / Turkish Neurosurgery / 2015 / Cilt: 25 - Sayı: 5

5-Aminolevulinic Acid-Induced Fluorescence in Cerebellar Primary Central nervous System Lymphoma: A Case Report and Literature Review

Serebellar Yerleşimli Primer Santral Sinir Sistemi Lenfomasında 5-Aminolevülinik Asit ile İndüklenmiş Floresans: Olgu Sunumu ve Literatür Derlemesi

Pages
796–800
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Together with previous reports, this case study emphasizes the efficacy of the surgical application of 5-ALA for PCNSL.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:5-Aminolevulinic acid (5-ALA)-induced fluorescence-guided resection is a widely used procedure for patients with malignant gliomas.
📊
Key Findings & Data:However, the clinical application of 5-ALA for surgery in primary central nervous system lymphoma (PCNSL) is uncommon.
💡
Conclusion & Impact:Together with previous reports, this case study emphasizes the efficacy of the surgical application of 5-ALA for PCNSL.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

5-Aminolevulinic acid (5-ALA)-induced fluorescence-guided resection is a widely used procedure for patients with malignant gliomas. However, the clinical application of 5-ALA for surgery in primary central nervous system lymphoma (PCNSL) is uncommon. Here, we present a case of PCNSL treated using 5-ALA-induced fluorescence-guided resective surgery. A 70-year-old woman presented with cerebellar ataxia, and magnetic resonance imaging revealed an irregularly shaped and homogenously enhanced mass with surrounding brain edema in the vermis that extended to the right hemisphere of the cerebellum. Under the preoperative diagnosis of a malignant glioma in the cerebellum, the patient underwent 5-ALA-induced fluorescence-guided surgery. Under blue light illumination, the tumor revealed strong 5-ALA-induced fluorescence. The tumor was identified as a diffuse large B-cell lymphoma. After partial resection, the patient received adjuvant chemotherapy and radiotherapy. Importantly, the neurological deficit of the patient improved, and recurrence of the tumor was not observed 21 months post-surgery. Together with previous reports, this case study emphasizes the efficacy of the surgical application of 5-ALA for PCNSL.

Özet

5-Aminolevülinik asit (5-ALA) ile indüklenmiş floresans-eşliğinde rezeksiyon malign gliomalı hastalarda yaygın kullanılan bir tekniktir. Ancak primer santral sinir sistemi lenfoması (PSSSL) olan hastaların cerrahisinde 5-ALA kullanımı sık değildir. Burada 5-ALA ile indüklenmiş floresans eşliğinde rezektif cerrahi uygulanan bir PSSSL olgusu sunuldu. Serebellar ataksi ile başvuran 70 yaşındaki kadın hastada manyetik rezonans görüntüleme, vermisden sağ serebellar hemisfere uzanan, düzensiz sınırlı ve homojen kontrast tutan, çevre beyin dokusunda ödeme nedene olan kitle lezyonunu ortaya koydu. Preoperatif olarak serebellumda malign glioma tanısı düşünüldü ve hastaya 5-ALA ile indüklenmiş floresans eşliğinde cerrahi uygulandı. Mavi ışık aydınlatması altında tümör kuvvetli 5-ALA ile indüklenmiş floresans gösterdi. Tümörün histopatolojik inceleme sonucu diffüz geniş B-hücreli lenfoma olarak geldi. Kısmi rezeksiyondan sonra hastaya ilave kemoterapi ve radyoterapi uygulandı. Önemli olarak, hastanın nörolojik defisiti düzeldi ve cerrahiden 21 ay sonra nüks gözlenmedi. Bu konudaki daha önceki raporlarla birlikte, bu olgu çalışması da 5-ALA'nın PSSSL'da cerrahi uygulamasının etkinliğini vurgulamaktadır.

🔖

Cite This Article

NISHIZAWA, S., YAMAMOTO, J., KITAGAWA, T., AKIBA, D. (2022). 5-Aminolevulinic Acid-Induced Fluorescence in Cerebellar Primary Central nervous System Lymphoma: A Case Report and Literature Review. Turkish Neurosurgery, Cilt: 25 - Sayı: 5, 796–800. https://ajindex.com/articles/616983

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (1)

  1. Cage TA, Pekmezci M, Prados M, Berger MS: Subependymal spread of recurrent glioblastoma detected with the intraoperative use of 5-aminolevulinic acid: Case report. J Neurosurg 118:1220-1223, 2013 2. Grossman R, Nossek E, Shimony N, Raz M, Ram Z: Intraoperative 5-aminolevulinic acid-induced fluorescence in primary central nervous system lymphoma. J Neurosurg 120:67-69, 2014 3. Hayashi Y, Nakada M, Tanaka S, Uchiyama N, Kita D, Hamada J: Implication of 5-aminolevulinic acid fluorescence of the ventricular wall for postoperative communicating hydrocephalus associated with cerebrospinal fluid dissemination in patients with glioblastoma multiforme: A report of 7 cases. J Neurosurg 112:1015-1019, 2010 4. Hebeda KM, Saarnak AE, Olivo M, Sterenborg HJ, Wolbers JG: 5-Aminolevulinic acid induced endogenous porphyrin fluorescence in 9L and C6 brain tumours and in the normal rat brain. Acta Neurochir (Wien) 140:503-512; discussion 12- 13, 1998 5. Hefti M, von Campe G, Moschopulos M, Siegner A, Looser H, Landolt H: 5-aminolevulinic acid induced protoporphyrin IX fluorescence in high-grade glioma surgery: A one-year experience at a single institutuion. Swiss Med Wkly 138: 180-185, 2008 6. Hiraga S, Arita N, Ohnishi T, Kohmura E, Yamamoto K, Oku Y, et al: Rapid infusion of high-dose methotrexate resulting in enhanced penetration into cerebrospinal fluid and intensified tumor response in primary central nervous system lymphomas. J Neurosurg 91:221-230, 1999 7. Jack CR Jr, Reese DF, Scheithauer BW: Radiographic findings in 32 cases of primary CNS lymphoma. AJR Am J Roentgenol 146:271-276, 1986 8. Moriuchi S, Yamada K, Dehara M, Teramoto Y, Soda T, Imakita M, et al: Use of 5-aminolevulinic acid for the confirmation of deep-seated brain tumors during stereotactic biopsy. Report of 2 cases. J Neurosurg 115:278-280, 2011 9. Novotny A, Xiang J, Stummer W, Teuscher NS, Smith DE, Keep RF: Mechanisms of 5-aminolevulinic acid uptake at the choroid plexus. J Neurochem 75:321-328, 2000 10. Stummer W, Pichlmeier U, Meinel T, Wiestler OD, Zanella F, Reulen HJ: Fluorescence-guided surgery with 5-aminolevulinic acid for resection of malignant glioma: A randomised controlled multicentre phase III trial. Lancet Oncol 7:392-401, 2006 11. Stummer W, Reulen HJ, Novotny A, Stepp H, Tonn JC: Fluorescence-guided resections of malignant gliomas-an overview. Acta Neurochir Suppl 88:9-12, 2003 12. Utsuki S, Oka H, Fujii K: Intraoperative photodynamic diagnosis of brain tumors using 5-aminolevlun